The study uses data from the Yale Open Data Access Project which included 10 industry-sponsored randomized controlled trials of rhBMP-2. The researchers found:
1. Primary support for rhBMP-2 improving outcomes for patients in these categories:
· Smokers
· Younger patients under 60 years old
· Normal weight patients
2. The rhBMP-2 wasn’t associated with improved outcomes for patients in these groups:
· Non-smokers
· Patients older than 60 years old
· Obese
· Severely obese
3. There were decreased harms in patients without previous back surgery associated with rhBMP-2. However, patients who had previous spinal surgeries didn’t see the same improvements.
4. The researchers concluded patient characteristics could have an impact on outcomes for spinal fusions with rhBMP-2.
5. The study authors recommended additional research into the subgroups associated with better outcomes to identify patients who are most likely to benefit.
More articles on spine surgery:
Are magnetically controlled growing rods effective for early scoliosis? 5 key notes
Dr. Jonathan Falakassa joins Southern California Orthopedic Institute: 5 key notes
Prestige LP cervical arthroplasty vs. spinal fusion: 6 key notes on 7-year data
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
